However, this overall finding may reflect an interaction of IL-6 with obesity; that is, higher levels of IL-6 may be associated with higher insulin sensitivity and capillary density among normal-weight individuals (beneficial effect), but an inverse (harmful) relationship may exist with these outcomes among obese individuals. This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.